Shawn Egan

Stock Analyst at Citigroup

(2.01)
# 2,975
Out of 4,944 analysts
5
Total ratings
100%
Success rate
2.06%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Shawn Egan

Arrowhead Pharmaceuticals
May 13, 2025
Maintains: Neutral
Price Target: $21$17
Current: $19.99
Upside: -14.96%